Back to Market Feed

Product Information

QUININE SULFATE 324 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.6367 per EA under NDC 00093300256. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Sep 28, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

QUININE SULFATE 324 MG CAPSULE

Quinine Sulfate
$0.6367per EA

Strength

324 mg/1

NDC

00093300256

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

QUININE SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA091661

FDA Approved

9/28/2012

TE Code

AB

On Market Since

9/28/2012

Pharmacological Classes

Antimalarial

Price Statistics

The NADAC for QUININE SULFATE 324 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 87.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6367 per EA
All-time high$5.5900 (Jul 16, 2014)
All-time low$0.6067 (Jan 17, 2024)
52-week high$0.7882
52-week low$0.6367
Median price$1.6954
Average price$2.4325
Largest weekly change+52.1% (Mar 20, 2024)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-5.3%

1M

-5.3%

3M

-15.7%

6M

-19.2%

1Y

-10.5%

3Y

-29.8%

5Y

-54.0%

All

-87.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Quinine Sulfate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

HYDROXYCHLOROQUINE 200 MG TAB
Generic
00093240101•Teva Pharmaceuticals USA Inc.
$0.1485
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
00904704606•Major Pharmaceuticals
$0.1485
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
00904704661•Major Pharmaceuticals
$0.1485
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16571011201•Rising Pharma Holdings Inc.
$0.1485
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16571011250•Rising Pharma Holdings Inc.
$0.1485
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16714011001•NorthStar Rx LLC
$0.1485
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16714011002•NorthStar Rx LLC
$0.1485
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16729048501•Accord Healthcare Inc.
$0.1485
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16729048516•Accord Healthcare Inc.
$0.1485
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
43598072101•Dr. Reddy's Laboratories Inc.
$0.1485
per EA

Frequently asked questions

What is the NADAC price of QUININE SULFATE 324 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for QUININE SULFATE 324 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $0.6367 per EA (NDC 00093300256), effective Aug 19, 2026.

How has the price of QUININE SULFATE 324 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for QUININE SULFATE 324 MG CAPSULE has declined 87.9%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for QUININE SULFATE 324 MG CAPSULE?

Since Nov 28, 2013, the NADAC for QUININE SULFATE 324 MG CAPSULE has ranged from a low of $0.6067 (Jan 17, 2024) to a high of $5.5900 (Jul 16, 2014), with a median of $1.6954 per EA.

Are there cheaper alternatives to QUININE SULFATE 324 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of QUININE SULFATE 324 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures QUININE SULFATE 324 MG CAPSULE?

QUININE SULFATE 324 MG CAPSULE (NDC 00093300256) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.